EUVIMEDEUVIMED entdecken
Evaluationsstudie

Cefepime susceptibility testing in AmpC-hyperproducing Enterobacter cloacae complex: limitations of routine methods and a pragmatic diagnostic approach

Carmen Fernández-Bermudo, Marta Rodríguez-Rodríguez, José Manuel Ortiz de la Rosa, Carmen Soto-Gallego, José Antonio Lepe, Ángel Rodríguez-Villodres iD

European Journal of Clinical Microbiology & Infectious Diseases · 2026-11 · 45 (11) · 3533-3540

DOI: 10.1007/s10096-026-05605-2 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 18.07.2026. Verfasst von Carmen Fernández-Bermudo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen Del Rocío, Seville, Spain. Hauptthemen laut MEDLINE: Enterobacter cloacae, Cefepime, Anti-Bacterial Agents, beta-Lactamases. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Servicio Andaluz de Salud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We compared and evaluated three routine methods (MicroScan, gradient diffusion and disk diffusion) with broth microdilution (BMD) for cefepime against 200 AmpC-hyperproducing Enterobacter cloacae complex isolates. Reference BMD classified 40.0% as susceptible, 39.5% as susceptible with increased exposure, and 20.5% as resistant to cefepime, according to EUCAST criteria. Categorical agreement (CA) was 63.5% for MicroScan, 73.5% for gradient diffusion, and 69.5% for disk diffusion. MicroScan showed the highest sensitivity for detecting BMD-defined resistance (82.9%) but moderate specificity (71.0%), whereas gradient diffusion and disk diffusion showed lower sensitivities (46.3% and 53.7%, respectively) but higher specificities (95.6% and 92.5%, respectively). Similar method-dependent patterns were observed using CLSI criteria. Error-rate-bound analysis confirmed that these discrepancies were not restricted to isolates with MICs close to the clinical breakpoints. A modified EUCAST-based stepwise algorithm improved the balance of performance compared with MicroScan alone, mainly by reducing overestimation of resistance, but clinically relevant misclassification persisted. Overall, no routine method or algorithm fully replaced BMD, supporting confirmatory reference testing when accurate cefepime categorization is clinically critical.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterobacter cloacaeCefepimeAnti-Bacterial Agentsbeta-LactamasesBacterial ProteinsHumansMicrobial Sensitivity TestsThird Generation CephalosporinsSensitivity and SpecificityEnterobacteriaceae Infections

Stichwörter der Autor:innen

Enterobacter cloacae complexAlgorithmAmpCCefepimeMIC determination

Substanzen

CefepimeAnti-Bacterial AgentsThird Generation Cephalosporinsbeta-LactamasesAmpC beta-lactamasesBacterial Proteins

Autor:innen und Institutionen

  • Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen Del Rocío, Seville, Spain.
  • Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Microbiology, University of Seville, Seville, Spain.
  • Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen Del Rocío, Seville, Spain. anrovi1797@gmail.com.
  • Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain. anrovi1797@gmail.com.

ORCID-Profile: Ángel Rodríguez-Villodres

Förderung

  • Instituto de Salud Carlos III
  • Servicio Andaluz de Salud

Zitieren

APA

Fernández-Bermudo, C., Rodríguez-Rodríguez, M., de la Rosa, J. M. O., Soto-Gallego, C., Lepe, J. A., & Rodríguez-Villodres, Á. (2026). Cefepime susceptibility testing in AmpC-hyperproducing Enterobacter cloacae complex: limitations of routine methods and a pragmatic diagnostic approach. European Journal of Clinical Microbiology & Infectious Diseases, 45(11), 3533-3540. https://doi.org/10.1007/s10096-026-05605-2

Vancouver

Fernández-Bermudo C, Rodríguez-Rodríguez M, de la Rosa JMO, Soto-Gallego C, Lepe JA, Rodríguez-Villodres Á. Cefepime susceptibility testing in AmpC-hyperproducing Enterobacter cloacae complex: limitations of routine methods and a pragmatic diagnostic approach. European Journal of Clinical Microbiology & Infectious Diseases. 2026;45(11):3533-3540. doi:10.1007/s10096-026-05605-2

BibTeX
@article{FernndezBermudo2026,
  author = {Fernández-Bermudo, Carmen and Rodríguez-Rodríguez, Marta and de la Rosa, José Manuel Ortiz and Soto-Gallego, Carmen and Lepe, José Antonio and Rodríguez-Villodres, Ángel},
  title = {Cefepime susceptibility testing in AmpC-hyperproducing Enterobacter cloacae complex: limitations of routine methods and a pragmatic diagnostic approach},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {3533--3540},
  doi = {10.1007/s10096-026-05605-2}
}
Kostenlos starten →